• Asian-Australasian Journal of Animal Sciences
• /
• 제18권2호
• /
• pp.241-248
• /
• 2005

This study is aimed at understanding the role of arsenic in Roxarsone in causing fatty livers in mule ducks. One hundred 10-week-old mule ducks were randomly divided into 5 groups. Ducks received 2 weeks of various treatments followed by 2 weeks of withdrawal. The treatments were non-treatment (control), 300 mg/kg Roxarsone inclusion for 2 weeks ($1^{st}$ and $2^{nd}$ week), Roxarsone inclusion for one week ($2^{nd}$ week only), restrict feeding, or Roxarsone analogue (3-nitro-4-hydroxyphenyl acid) inclusion. Results showed that feed intake and body weight in the Roxarsone groups and the restrict feeding group decreased significantly during the treatment period. However only the liver and heart weights were significantly decreased (p<0.05) in the restrict feeding group. Fatty acid synthetase (FAS) activity showed a significant decrease (p<0.05) in the Roxarsone groups and the restrict feeding group, two-week-Roxarsone treatment significantly increased NADP-malic dehydrogenase (MDH) activity compared to the restrict (p<0.05). After 2 weeks drug withdrawal, the 1-week-Roxarsone or restrict feeding group showed significantly increased (p<0.05) glucose-6-phosphate dehydrogenase (G-6-PDH) activity (p<0.05). Two-week-Roxarsone treatment significantly decreased (p<0.05) the high density lipoprotein (HDL) and increased (p<0.05) the low density lipoprotein (LDL) and very low density lipoprotein (VLDL) ratio. After drug withdrawal, the 1-week-Roxarsone or restrict feeding group showed significantly increased (p<0.05) creatine kinase (CK) activity. The 2-week-Roxarsone treatment group showed significantly increased (p<0.05) aspartate aminotransferase (AST) activity. The restrict feeding treatment group showed significantly decreased (p<0.05) total protein (TP) concentration. After drug withdrawal, the related enzyme activities in the blood that reflected the liver function were restored to the normal physiological range, except for the total bilirubin concentration and CK activity in the 1-week-Roxarsone group. This group showed a significant increase (p<0.05). Thus, the reasons for liver enlargement in the Roxarsone and restrict feeding groups were different.

• Asian-Australasian Journal of Animal Sciences
• /
• 제19권3호
• /
• pp.412-417
• /
• 2006

This study evaluated the effectiveness of different arsenical sources on inducing fatty liver, on changes in lipid metabolism and on liver function in mule ducks. Sixty twelve-week-old mule ducks were selected and randomly divided into five treatments, including the control group and four different arsenical sources; Roxarsone (300 mg/kg), arsanilic acid, $As_2O_5$ or $As_2O_3$, containing 85.2 mg/kg arsenic were included in the basal diet. The ducks were fed the medicated basal diet for 3 weeks followed by a one-week drug withdrawal. The results showed Roxarsone treatment decreased body weight, feed intake, liver weight and abdominal fat weight (p<0.05), while it increased the relative liver weight (p<0.05) during medication period ($3^{rd}$ week). The $As_2O_5$ treatment decreased abdominal fat weight and relative abdominal fat weight when compared to the control (p<0.05). Only Roxarsone among the treatment groups increased feed intake, liver weight and relative liver weight, while the $As_2O_3$ group showed the lightest liver weight and relative liver weight among treatment groups during the withdrawal period ($4^{th}$ week). The Roxarsone group decreased (p<0.05) NADP-malic dehydrogenase (MDH) and acetyl-CoA carboxylase (ACC) activities and increased (p<0.05) cholesterol concentration during the medication period, and elevated the MDH and ACC activities during the withdrawal period. All four arsenical treatment groups showed lymphocytic infiltration in liver tissue, while the Roxarsone and $As_2O_3$ treatments showed an increase in aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) activities (p<0.05). During the withdrawal period, arsenical treatments resulted in liver vacuoles. However, the arsenicals differed in effectiveness and mechanisms of inducing fat vacuoles.

• Asian-Australasian Journal of Animal Sciences
• /
• 제19권1호
• /
• pp.48-54
• /
• 2006

Roxarsone (3-nitro-4-hydroxyphenylarsonic acid) has been used as feed additives in poultry industries to improve production and control coccidiosis. The effect of high dietary levels of Roxarsone (ROX) on the performance and function of internal organs and the kinetics of recovery as well as its after-effects were examined in laying hens. The inclusion rates of ROX were 0, 100, 200, 300, and 400 mg per kg feed. Inclusion up to 200 mg did not show any adverse effects (p>0.05), whereas in the 300 and 400 mg groups, significant effects, particularly in the latter, were observed for three weeks after ROX addition (p<0.05). Recovery of the physical appearance occurred soon after ROX addition was withdrawn. Recovery of performance and internal organs, however, appeared to be dependent on the amount of residual ROX in the body; as the amount of ROX decreased, the toxic effect of ROX also decreased. In the third week after the withdrawal of ROX, complete recovery was observed in the lower dosage groups (100 or 200 mg groups) (p>0.05), whereas in the higher dosage groups (300 or 400 mg groups), recovery took at least five weeks; when complete recovery was observed in egg production and in liver weight (p>0.05). On the other hand, ROX might have damaged the liver and other tissues. The recovery of liver weight was probably due to accumulation of fatty particles rather than repair. It appeared, therefore, there were little after-effects of ROX on the hen's physical appearance, but some internal organs were probably damaged.

• 대한환경공학회지
• /
• 제32권6호
• /
• pp.631-638
• /
• 2010

다양한 오염원을 통해 토양에 유입된 비소는 작물을 통해 인체로 전이되어 심각한 질환을 유발한다. 특히 가금류 사료에 첨가되는 록살슨(roxarsone)의 경우 퇴비 중에 포함되어 토양으로 유입되면 독성이 강한 무기비소로 변환된다. 본 연구에서는 비소 오염토양의 안정화 공법 적용을 위해 산업부산물인 영가철과 제강슬래그를 투입하여 토양 내 비소의 안정화 연구를 수행하였다. 비소(무기비소)와 록살슨(유기비소)으로 오염된 토양에 영가철 및 제강슬래그를 0%(w/w), 1%(w/w), 3%(w/w), 5%(w/w) 처리하고 30일 간 반응시킨 후 비소의 저감정도를 살펴본 결과 왕수추출에 의한 비소의 총함량은 무처리구에서 비소 오염토양이 2,285 mg/kg, 록살슨 오염토양이 6.5 mg/kg으로 나타났다. 1 N HCl 가용성 비소는 비소 오염토양의 무처리구가 1,351 mg/kg, 영가철 처리구가 713~1,034 mg/kg로 무처리구 대비 최대 40% 이상 감소하였다. 제강슬래그 처리구의 경우 1 N HCl 가용성 비소농도가 소폭으로 감소하였으며 5% 처리구(1,245 mg/kg)에서 통계적으로 유의성 있는 감소효과가 나타났다. 록살슨 오염토양에서는 영가철 1~5% 처리 시 비소의 농도가 0.69~3.13 mg/kg으로 처리 간에 유의성 있게 감소하는 경향을 나타내었으며 제강슬래그의 처리는 통계적으로 유의성 있는 감소효과는 발생하지 않았다. 특히 록살슨 오염토양은 영가철과 제강슬래그 처리 시 검출되는 비소의 양이 무처리구보다 증가하는 것으로 나타나 유기비소인 록살슨이 무기비소로 변환되는 과정에서 영가철과 제강슬래그가 영향을 끼친 것으로 판단되었다. 0.01 M $CaCl_2$ 에 의한 추출(유효태 비소) 결과 비소오염토양의 무처리구 유효태 비소농도는 0.85 mg/kg, 영가철 5% 처리구에서 0.06 mg/kg 로 무처리구 대비 90% 이상 감소하였다. 비소오염토양에 대한 제강슬래그 처리에서는 제강슬래그에 함유된 인과 토양 내 비소가 경쟁하면서 처리량이 증가함에 따라 비소농도가 증가하였다. 록살슨 오염토양의 경우 영가철과 제강슬래그 처리량 증가에 따라 비소의 농도가 감소하였으나 무처리구에 비하여 비소가 높게 검출되었다. 이는 토양에 투입된 영가철과 제강슬래그가 유기비소에서 무기비소로의 변환과정에 영향을 준 것으로 판단된다. 특히 토양 내 인산과 비소는 철에 대해서 경쟁반응을 하는데 이는 영가철 처리 시 검출되는 비소농도에 영향을 미친 것으로 판단되었다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제25권3호
• /
• pp.382-392
• /
• 2012

This study evaluated the effects of dietary anticoccidial drugs plus antibiotic growth promoters (AGPs) on parameters of immunity in commercial broiler chickens. Day-old chicks were raised on used litter from a farm with endemic gangrenous dermatitis to simulate natural pathogen exposure and provided with diets containing decoquinate (DECX) or monensin (COBN) as anticoccidials plus bacitracin methylene disalicylate and roxarsone as AGPs. As a negative control, the chickens were fed with a non-supplemented diet. Immune parameters examined were concanavalin A (ConA)-stimulated spleen cell proliferation, intestine intraepithelial lymphocyte (IEL) and spleen cell subpopulations, and cytokine/chemokine mRNA levels in IELs and spleen cells. ConA-induced proliferation was decreased at 14 d post-hatch in DECX-treated chickens, and increased at 25 and 43 d in COBN-treated animals, compared with untreated controls. In DECX-treated birds, increased percentages of $MHC2^+$ and $CD4^+$ IELS were detected at 14 d, but decreased percentages of these cells were seen at 43 d, compared with untreated controls, while increased $TCR2^+$ IELs were evident at the latter time. Dietary COBN was associated with decreased fractions of $MHC2^+$ and $CD4^+$ IELs and reduced percentages of $MHC2^+$, $BU1^+$, and $TCR1^+$ spleen cells compared with controls. The levels of transcripts for interleukin-4 (IL-4), IL-6, IL-17F, IL-13, CXCLi2, interferon-${\gamma}$ (IFN-${\gamma}$), and transforming growth factor${\beta}$4 were elevated in IELs, and those for IL-13, IL-17D, CXCLi2, and IFN-${\gamma}$ were increased in spleen cells, of DECX- and/or COBN-treated chickens compared with untreated controls. By contrast, IL-2 and IL-12 mRNAs in IELs, and IL-4, IL-12, and IL-17F transcripts in spleen cells, were decreased in DECX- and/or COBN-treated chickens compared with controls. These results suggest that DECX or COBN, in combination with bacitracin and roxarsone, modulate the development of the chicken post-hatch immune system.